Work

Author response: Utilization of rehabilitation therapy services in Parkinson disease in the United States

Year: 2018

Type: peer-review

Abstract: We thank Drs. Bryant and Protas for the comment on our article,1 and for pointing out their supportive study.2 Together, our data suggest that underutilization of rehabilitation therapies in Parkinson disease (PD) is persistent and pervasive. During the time period of these 2 studies, several randomized controlled trials were published that supported the use of rehabilitation therapies in PD.3,4 Improvements in mobility, activities of daily living, speech volume, and quality of life were demonstrated in these and other studies. This is another example of the gap between PD research and implementation. The barriers to dissemination of proven treatments need to be addressed for PD outcomes to improve.

Source: Neurology

DOI: 10.1212/wnl.0000000000005367

Authors: Michelle E. Fullard, Allison W. Willis

Language: English

Topic: Parkinson's Disease Mechanisms and Treatments

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Institute of Neurological Disorders and Stroke

Award: Impact of Anticholinergic and Dopamine Receptor Blocking Drug Exposure on Parkinson Disease Trajectory and Outcomes